Heart : official journal of the British Cardiac Society
-
Review Meta Analysis
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
HCM is commonly associated with AF. Current guidelines for AF management omit detailed advice for HCM because of a lack of clinical prediction tools that estimate the risk of developing AF and an absence of adequately powered treatment studies. ⋯ AF is common in HCM and associated with high thromboembolic risk. LA dimension and age are independently associated with AF but the literature is insufficient to create robust clinical tools to predict AF or thromboembolism. Most data suggest that AF patients should be anticoagulated.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention.
β-blockers are the standard treatment for myocardial infarction (MI) based on evidence from the pre-thrombolytic era. The aim of this study was to examine the effect of β-blocker treatment in patients with acute MI and preserved systolic function in the era of percutaneous coronary intervention (PCI). ⋯ β-blocker treatment was associated with reduced long term mortality in patients with acute MI and preserved systolic function who received PCI.